No Vaccine, No Cure

Editor's Note: This is the second of two articles that looks at the progression of AIDS research over the 20 years since its identification. The first part: M.E. Watanabe, "AIDS, 20 years later," The Scientist, 15[12]:1, June 11, 2001. Despite billions of dollars spent in research funds and a brief reprieve in Western nations after the introduction of multidrug therapy, AIDS continues to win its battle against humankind. First diagnosed 20 years ago, there are still no cures and no vaccines. Pre

| 10 min read

Register for free to listen to this article
Listen with Speechify
0:00
10:00
Share

When first diagnosed in the United States, the disease mainly struck gay men, intravenous drug abusers, and those who had received tainted blood or blood products. Today, its targets have changed. AIDS thrives in poverty and among those who are disenfranchised. Increasingly, it is becoming a disease affecting women and children: worldwide, in 2000, 2.2 million of the 4.7 million new HIV infections were in women.1

In the United States, "it continues to disproportionately [strike] communities of color," says Helene Gayle, the outgoing director of the Centers for Disease Control and Prevention National Center for HIV, STD, and TB Prevention. "Almost 70 percent of new HIV infections are among African Americans and Latinos." Moreover, the prevalence of AIDS in gay men in the United States is no longer declining, after years of decreasing. "It's not enough to tell people that this is AIDS and how you get it," says Karungari ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

  • Myrna Watanabe

    This person does not yet have a bio.

Published In

Share
TS Digest January 2025
January 2025, Issue 1

Why Do Some People Get Drunk Faster Than Others?

Genetics and tolerance shake up how alcohol affects each person, creating a unique cocktail of experiences.

View this Issue
Sex Differences in Neurological Research

Sex Differences in Neurological Research

bit.bio logo
New Frontiers in Vaccine Development

New Frontiers in Vaccine Development

Sino
New Approaches for Decoding Cancer at the Single-Cell Level

New Approaches for Decoding Cancer at the Single-Cell Level

Biotium logo
Learn How 3D Cell Cultures Advance Tissue Regeneration

Organoids as a Tool for Tissue Regeneration Research 

Acro 

Products

Artificial Inc. Logo

Artificial Inc. proof-of-concept data demonstrates platform capabilities with NVIDIA’s BioNeMo

Sapient Logo

Sapient Partners with Alamar Biosciences to Extend Targeted Proteomics Services Using NULISA™ Assays for Cytokines, Chemokines, and Inflammatory Mediators

Bio-Rad Logo

Bio-Rad Extends Range of Vericheck ddPCR Empty-Full Capsid Kits to Optimize AAV Vector Characterization

Scientist holding a blood sample tube labeled Mycoplasma test in front of many other tubes containing patient samples

Accelerating Mycoplasma Testing for Targeted Therapy Development